IRF4 at the crossroads of effector T-cell fate decision

European Journal of Immunology

Volumn 44, Issue 7, 2014, Pages 1886-1895

  Huber, Magdalena ^a   Lohoff, Michael ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Interferon regulatory factor 4; T cell differentiation; T cell subsets

Indexed keywords

CD4+ T CELLS; CD8+ T CELLS; INTERFERON REGULATORY FACTOR 4; T-CELL DIFFERENTIATION; T-CELL SUBSETS;

ANIMALS; CELL DIFFERENTIATION; HUMANS; INTERFERON REGULATORY FACTORS; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 84904397782     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344279     Document Type: Review

References (75)

1. Shaffer, A. L., Emre, N. C., Romesser, P. B. and Staudt, L. M., IRF4: immunity. Malignancy! Therapy? Clin. Cancer Res. 2009. 15: 2954-2961.
2. Pongubala, J. M., Nagulapalli, S., Klemsz, M. J., McKercher, S. R., Maki, R. A. and Atchison, M. L., PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol. Cell Biol. 1992. 12: 368-378.
3. Matsuyama, T., Grossman, A., Mittrucker, H. W., Siderovski, D. P., Kiefer, F., Kawakami, T., Richardson, C. D., et al., Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 1995. 23: 2127-2136.
4. De Silva, N. S., Simonetti, G., Heise, N. and Klein, U., The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev. 2012. 247: 73-92.
5. Gao, Y., Nish, S. A., Jiang, R., Hou, L., Licona-Limon, P., Weinstein, J. S., Zhao, H. et al., Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity 2013. 39: 722-732.
6. Lohoff, M. and Mak, T. W., Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 2005. 5: 125-135.
7. Murphy, T. L., Tussiwand, R. and Murphy, K. M., Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat. Rev. Immunol. 2013. 13: 499-509.
8. Persson, E. K., Uronen-Hansson, H., Semmrich, M., Rivollier, A., Hagerbrand, K., Marsal, J., Gudjonsson, S. et al., IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 2013. 38: 958-969.
9. Schlitzer, A., McGovern, N., Teo, P., Zelante, T., Atarashi, K., Low, D., Ho, A. W. et al., IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 2013. 38: 970-983.
10. Tamura, T., Yanai, H., Savitsky, D. and Taniguchi, T., The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 2008. 26: 535-584.
11. Brass, A. L., Zhu, A. Q. and Singh, H., Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J 1999. 18: 977-991.
12. Biswas, P. S., Bhagat, G. and Pernis, A. B., IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol. Rev. 2010. 233: 79-96.
13. Escalante, C. R., Brass, A. L., Pongubala, J. M., Shatova, E., Shen, L., Singh, H. and Aggarwal, A. K., Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol. Cell 2002. 10: 1097-1105.
14. Li, P., Spolski, R., Liao, W., Wang, L., Murphy, T. L., Murphy, K. M. and Leonard, W. J., BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 2012. 490: 543-546.
15. Tussiwand, R., Lee, W. L., Murphy, T. L., Mashayekhi, M., Wumesh, K. C., Albring, J. C., Satpathy, A. T. et al., Compensatory dendritic cell development mediated by BATF-IRF interactions. Nature 2012. 490: 502-507.
16. Glasmacher, E., Agrawal, S., Chang, A. B., Murphy, T. L., Zeng, W., Vander Lugt, B., Khan, A. A. et al., A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 2012. 338: 975-980.
17. Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A. et al., A validated regulatory network for Th17 cell specification. Cell 2012. 151: 289-303.
18. Gupta, S., Jiang, M., Anthony, A. and Pernis, A. B., Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4. J. Exp. Med. 1999. 190: 1837-1848.
19. Zheng, Y., Chaudhry, A., Kas, A., de Roos, P., Kim, J. M., Chu, T. T., Corcoran, L. et al., Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009. 458: 351-356.
20. Ouyang, X., Zhang, R., Yang, J., Li, Q., Qin, L., Zhu, C., Liu, J. et al., Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat. Commun. 2011. 2: 314-325.
21. Tamiya, T., Ichiyama, K., Kotani, H., Fukaya, T., Sekiya, T., Shichita, T., Honma, K. et al., Smad2/3 and IRF4 play a cooperative role in IL-9-producing T cell induction. J. Immunol. 2013. 191: 2360-2371.
22. Man, K., Miasari, M., Shi, W., Xin, A., Henstridge, D. C., Preston, S., Pellegrini, M. et al., The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat. Immunol. 2013. 14: 1155-1165.
23. Raczkowski, F., Ritter, J., Heesch, K., Schumacher, V., Guralnik, A., Hocker, L., Raifer, H. et al., The transcription factor interferon regulatory factor 4 is required for the generation of protective effector CD8+ T cells. Proc. Natl. Acad. Sci. USA 2013. 110: 15019-15024.
24. Huber, M., Heink, S., Pagenstecher, A., Reinhard, K., Ritter, J., Visekruna, A., Guralnik, A. et al., IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J. Clin. Invest. 2013. 123: 247-260.
25. Yao, S., Buzo, B. F., Pham, D., Jiang, L., Taparowsky, E. J., Kaplan, M. H. and Sun, J., Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity 2013. 39: 833-845.
26. Nayar, R., Enos, M., Prince, A., Shin, H., Hemmers, S., Jiang, J. K., Klein, U. et al., TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation. Proc. Natl. Acad. Sci. USA 2012. 109: E2794-2802.
27. Grumont, R. J. and Gerondakis, S., Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappa B. J. Exp. Med. 2000. 191: 1281-1292.
28. Durant, L., Watford, W. T., Ramos, H. L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H. et al., Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010. 32: 605-615.
29. Goswami, R., Jabeen, R., Yagi, R., Pham, D., Zhu, J., Goenka, S. and Kaplan, M. H., STAT6-dependent regulation of Th9 development. J. Immunol. 2012. 188: 968-975.
30. Gokmen, M. R., Dong, R., Kanhere, A., Powell, N., Perucha, E., Jackson, I., Howard, J. K. et al., Genome-wide regulatory analysis reveals that T-bet controls Th17 lineage differentiation through direct suppression of IRF4. J. Immunol. 2013. 191: 5925-5932.
31. Chang, H. C., Zhang, S., Thieu, V. T., Slee, R. B., Bruns, H. A., Laribee, R. N., Klemsz, M. J. et al., PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 2005. 22: 693-703.
32. Zhu, J., Yamane, H. and Paul, W. E., Differentiation of effector CD4 T cell populations Annu. Rev. Immunol. 2010. 28: 445-489.
33. Liu, X., Nurieva, R. I. and Dong, C., Transcriptional regulation of follicular T-helper (Tfh) cells. Immunol. Rev. 2013. 252: 139-145.
34. Josefowicz, S. Z., Lu, L. F. and Rudensky, A. Y., Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 2012. 30: 531-564.
35. Korn, T., Bettelli, E., Oukka, M. and Kuchroo, V. K., IL-17 and Th17 cells. Annu. Rev. Immunol. 2009. 27: 485-517.
36. Rengarajan, J., Mowen, K. A., McBride, K. D., Smith, E. D., Singh, H. and Glimcher, L. H., Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J. Exp. Med. 2002. 195: 1003-1012.
37. Tominaga, N., Ohkusu-Tsukada, K., Udono, H., Abe, R., Matsuyama, T. and Yui, K., Development of Th1 and not Th2 immune responses in mice lacking IFN-regulatory factor-4. Int. Immunol. 2003. 15: 1-10.
38. Lohoff, M., Mittrucker, H. W., Prechtl, S., Bischof, S., Sommer, F., Kock, S., Ferrick, D. A. et al., Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc. Natl. Acad. Sci. USA 2002. 99: 11808-11812.
39. Hu, C. M., Jang, S. Y., Fanzo, J. C. and Pernis, A. B., Modulation of T cell cytokine production by interferon regulatory factor-4. J. Biol. Chem. 2002. 277: 49238-49246.
40. Sacks, D. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002. 2: 845-858.
41. Lohoff, M., Mittrucker, H. W., Brustle, A., Sommer, F., Casper, B., Huber, M., Ferrick, D. A. et al., Enhanced TCR-induced apoptosis in interferon regulatory factor 4-deficient CD4(+) Th cells. J. Exp. Med. 2004. 200: 247-253.
42. Jabeen, R., Goswami, R., Awe, O., Kulkarni, A., Nguyen, E. T., Attenasio, A., Walsh, D. et al., Th9 cell development requires a BATF-regulated transcriptional network. J. Clin. Invest. 2013. 123: 4641-4653.
43. Betz, B. C., Jordan-Williams, K. L., Wang, C., Kang, S. G., Liao, J., Logan, M. R., Kim, C. H. et al., Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 2010. 207: 933-942.
44. Staudt, V., Bothur, E., Klein, M., Lingnau, K., Reuter, S., Grebe, N., Gerlitzki, B. et al., Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010. 33: 192-202.
45. Chang, H. C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G. L., Jabeen, R. et al., The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 2010. 11: 527-534.
46. Brustle, A., Heink, S., Huber, M., Rosenplanter, C., Stadelmann, C., Yu, P., Arpaia, E. et al., The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat. Immunol. 2007. 8: 958-966.
47. Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brustle, A., Weigmann, B., Atreya, R. et al., The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J. Clin. Invest 2008. 118: 2415-2426.
48. Mudter, J., Yu, J., Zufferey, C., Brustle, A., Wirtz, S., Weigmann, B., Hoffman, A. et al., IRF4 regulates IL-17A promoter activity and controls RORgammat-dependent Th17 colitis in vivo. Inflamm. Bowel. Dis. 2011. 17: 1343-1358.
49. Chen, Q., Yang, W., Gupta, S., Biswas, P., Smith, P., Bhagat, G. and Pernis, A. B., IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity 2008. 29: 899-911.
50. Biswas, P. S., Gupta, S., Chang, E., Song, L., Stirzaker, R. A., Liao, J. K., Bhagat, G. et al., Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J. Clin. Invest. 2010. 120: 3280-3295.
51. Schraml, B. U., Hildner, K., Ise, W., Lee, W. L., Smith, W. A., Solomon, B., Sahota, G. et al., The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009. 460: 405-409.
52. Kwon, H., Thierry-Mieg, D., Thierry-Mieg, J., Kim, H. P., Oh, J., Tunyaplin, C., Carotta, S. et al., Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. Immunity 2009. 31: 941-952.
53. Bollig, N., Brustle, A., Kellner, K., Ackermann, W., Abass, E., Raifer, H., Camara, B. et al., Transcription factor IRF4 determines germinal center formation through follicular T-helper cell differentiation. Proc. Natl. Acad. Sci. USA 2012. 109: 8664-8669.
54. Ochiai, K., Maienschein-Cline, M., Simonetti, G., Chen, J., Rosenthal, R., Brink, R., Chong, A. S. et al., Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity 2013. 38: 918-929.
55. Huber, M., Brustle, A., Reinhard, K., Guralnik, A., Walter, G., Mahiny, A., von Low, E. et al., IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 2008. 105: 20846-20851.
56. Ise, W., Kohyama, M., Schraml, B. U., Zhang, T., Schwer, B., Basu, U., Alt, F. W. et al., The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 2011. 12: 536-543.
57. Cretney, E., Kallies, A. and Nutt, S. L., Differentiation and function of Foxp3(+) effector regulatory T cells. Trends Immunol. 2013. 34: 74-80.
58. Cretney, E., Xin, A., Shi, W., Minnich, M., Masson, F., Miasari, M., Belz, G. T. et al., The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 2011. 12: 304-311.
59. Shrikant, P. A., Rao, R., Li, Q., Kesterson, J., Eppolito, C., Mischo, A. and Singhal, P., Regulating functional cell fates in CD8 T cells. Immunol. Res. 2010. 46: 12-22.
60. Kaech, S. M. and Cui, W., Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 2012. 12: 749-761.
61. Thaventhiran, J. E., Fearon, D. T. and Gattinoni, L., Transcriptional regulation of effector and memory CD8+ T cell fates. Curr. Opin. Immunol. 2013. 25: 321-328.
62. Chang, S. Y., Song, J. H., Guleng, B., Cotoner, C. A., Arihiro, S., Zhao, Y., Chiang, H. S. et al., Circulatory antigen processing by mucosal dendritic cells controls CD8(+) T cell activation. Immunity 2013. 38: 153-165.
63. Visekruna, A., Ritter, J., Scholz, T., Campos, L., Guralnik, A., Poncette, L., Raifer, H. et al., Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation. Eur. J. Immunol. 2013. 43: 606-618.
64. Hamada, H., Garcia-Hernandez Mde, L., Reome, J. B., Misra, S. K., Strutt, T. M., McKinstry, K. K., Cooper, A. M. et al., Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J. Immunol. 2009. 182: 3469-3481.
65. Intlekofer, A. M., Banerjee, A., Takemoto, N., Gordon, S. M., Dejong, C. S., Shin, H., Hunter, C. A. et al., Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008. 321: 408-411.
66. Huber, M., Heink, S., Grothe, H., Guralnik, A., Reinhard, K., Elflein, K., Hunig, T. et al., A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur. J. Immunol. 2009. 39: 1716-1725.
67. Hinrichs, C. S., Kaiser, A., Paulos, C. M., Cassard, L., Sanchez-Perez, L., Heemskerk, B., Wrzesinski, C. et al., Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 2009. 114: 596-599.
68. Lu, Y., Hong, B., Li, H., Zheng, Y., Zhang, M., Wang, S., Qian, J. et al., Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. Proc. Natl. Acad. Sci. USA 2014. 111: 2265-2270.
69. Mittrucker, H. W., Matsuyama, T., Grossman, A., Kundig, T. M., Potter, J., Shahinian, A., Wakeham, A. et al., Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997. 275: 540-543.
70. Kurachi, M., Barnitz, R. A., Yosef, N., Odorizzi, P. M., Diiorio, M. A., Lemieux, M. E., Yates, K. et al., The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8 T cells. Nat. Immunol. 2014. 15: 373-383.
71. Grusdat, M., McIlwain, D. R., Xu, H. C., Pozdeev, V. I., Knievel, J., Crome, S. Q., Robert-Tissot, C. et al., IRF4 and BATF are critical for CD8 T-cell function following infection with LCMV. Cell Death Differ. 2014. 21: 1050-1060.
72. Wang, R. and Green, D. R., Metabolic checkpoints in activated T cells. Nat. Immunol. 2012. 13: 907-915.
73. Yen, H. R., Harris, T. J., Wada, S., Grosso, J. F., Getnet, D., Goldberg, M. V., Liang, K. L. et al., Tc17 CD8 T cells: functional plasticity and subset diversity. J. Immunol. 2009. 183: 7161-7168.
74. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M. and Fugger, L., Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J. Pathol. 2008. 172: 146-155.
75. MacIver, N. J., Michalek, R. D. and Rathmell, J. C., Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013. 31: 259-283.